NCT03871699View on ClinicalTrials.gov

Ferric Carboximaltose on Intra-myocardial Iron Load in Patients With Heart Failure

PHASE4UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 30, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

February 28, 2021

Conditions
Cardiac FailureSystolic Heart FailureHeart Failure, Systolic
Interventions
DRUG

Ferric carboxymaltose

Administration of Ferric Carboxymaltose intravenously, one dose only.

Trial Locations (1)

90440050

Hospital Moinhos de Vento, Porto Alegre

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Hospital Moinhos de Vento

OTHER

NCT03871699 - Ferric Carboximaltose on Intra-myocardial Iron Load in Patients With Heart Failure | Biotech Hunter | Biotech Hunter